Área salud
Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial
Background Botulinum toxin A has emerged as an alternative treatment for patients who have contraindications to other therapies or as an adjuvant therapy in the treatment of androgenetic alopecia (AGA), although little is known about […]
